Tuesday | August 09, 2022 |
Market Status: CLOSED

Market News


FARMACEUTICA REMEDIA SA - RMAH

2021 Annual report clarifications

Release Date: 5/24/2022 6:30:10 PM

IRIS Code: E5637

 

Current report

according to ASF Regulation no. 5/2018

 

Report date:

24.05.2022

Name of issuer:

Farmaceutica  REMEDIA

Registered office:

Deva, 2 Nicolae Balcescu Blvd.

Tel/ fax no:

0254 22 32 60       /        0254 22 61 97

ORC no:

2115198

Trade Registry no:

J20 / 700 / 1991

Subscribed and paid-in capital:

RON 9.548.082

Regulated market:

Bucharest Stock Exchange, Standard Cathegory

 

Important events to report:

Dear investors,

 

          The Board of Administrators of Farmaceutica REMEDIA S.A. informs the shareholders about the erroneous mention of IAS 18 - Revenue, instead of IFRS 15 - Revenue from Contracts with Customers, in the Explanatory notes to the Consolidated and Unconsolidated Financial Statements for 2021:

         

1. The actual method of revenue recognition during 2021 was in accordance with IFRS 15 Revenue from Contracts with Customers, the basic principle of which is that an entity shall recognize revenue to describe the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

 

2. Due to an error in the Explanatory Notes, the standard applicable to revenue recognition (Note 3 Significant accounting policies) has not been updated, but the basic principles of the current standard (IFRS 15) have been followed.

 

3. In the financial auditor's report reference is made to the application of IAS 18 due to the omission of the update, but the basic principles of the standard in force (IFRS 15) have been respected.

 

4. According to the note issued by the financial auditor INTERAUDIT SRL (attached to this current report), a further analysis of the application of the revenue recognition principles under IFRS 15 has been performed and no differences in interpretation have been found that would have an impact on the consolidated and unconsolidated financial statements for 2021.

 

Additional information can be obtained by phone +40 254 223 260, contact persons: Elena CODREAN / Florin CADIA, or at the e-mail address investor@remedia.ro.

 

 

                                                          President of the Board of Administrators

 

 

                                                         „TARUS” – Valentin Norbert TARUS e.U.                                                                                                           

 



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved